Authors
Jason Yim, Reena Chopra, Terry Spitz, Jim Winkens, Annette Obika, Christopher Kelly, Harry Askham, Marko Lukic, Josef Huemer, Katrin Fasler, Gabriella Moraes, Clemens Meyer, Marc Wilson, Jonathan Dixon, Cian Hughes, Geraint Rees, Peng T Khaw, Alan Karthikesalingam, Dominic King, Demis Hassabis, Mustafa Suleyman, Trevor Back, Joseph R Ledsam, Pearse A Keane, Jeffrey De Fauw
Publication date
2020/6
Journal
Nature Medicine
Volume
26
Issue
6
Pages
892-899
Publisher
Nature Publishing Group US
Description
Progression to exudative ‘wet’ age-related macular degeneration (exAMD) is a major cause of visual deterioration. In patients diagnosed with exAMD in one eye, we introduce an artificial intelligence (AI) system to predict progression to exAMD in the second eye. By combining models based on three-dimensional (3D) optical coherence tomography images and corresponding automatic tissue maps, our system predicts conversion to exAMD within a clinically actionable 6-month time window, achieving a per-volumetric-scan sensitivity of 80% at 55% specificity, and 34% sensitivity at 90% specificity. This level of performance corresponds to true positives in 78% and 41% of individual eyes, and false positives in 56% and 17% of individual eyes at the high sensitivity and high specificity points, respectively. Moreover, we show that automatic tissue segmentation can identify anatomical changes before conversion and …
Total citations
202020212022202320241254627438
Scholar articles
J Yim, R Chopra, T Spitz, J Winkens, A Obika, C Kelly… - Nature Medicine, 2020